Import Authorisation Through VUCEN: The Fifteen Invoice Elements
Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
From 13 April 2026 every device import procedure in Nicaragua runs through the VUCEN platform. Circular ANRS-DDM-BRML-0001-03-2026, published on 25 March 2026, terminated the transitional provisions of RA 0020/2025 and fixed that date as the point from which the platform is the only route. The invoice must be a PDF and must carry at least fifteen elements under Article 7, item 2 of Anexo I to RA 0020/2025: product name, packaging specification, Nicaraguan registration number, consignor name, address and country, consignee name, address and country, imported quantity, invoice number, batch number, model, code or reference, unit price, total price, unit of measure, expiry date, weight and FOB value. Expiry dates must be written as dd/mm/aaaa; where the invoice shows only month and year, the last day of that month is used.
- VUCEN is the sole import route from 13 April 2026 (Circular 0001-03-2026).
- The invoice must be a PDF with at least fifteen elements (RA 0020/2025, Anexo I, Article 7 item 2).
- The registration number on the invoice must match the Nicaraguan registration.
- Expiry dates follow dd/mm/aaaa; a month-only date becomes the last day of that month.
- A rejected import application has no correction window and must be filed again (Article 8 item 6).
- Reconsideration and appeal each run for ten working days and are available once each (Articles 9 and 10).
2. Legal basis
Three instruments operate together: the resolution that created the platform procedure, the annex that fixes the invoice content, and the circular that ended the transition. The table sets out the provisions relied on.
| Administrative resolution | Resolución Administrativa N° 0020/2025 (issued 2 October 2025, effective 13 October 2025) | Operative parts PRIMERO, CUARTO | Device import procedures are handled entirely online through the VUCEN platform, effective 13 October 2025 |
| Administrative resolution | Resolución Administrativa N° 0020/2025 (issued 2 October 2025, effective 13 October 2025) | Anexo I, Article 7 items 1 and 2 | Payment receipt plus PDF invoice; the invoice must contain at least fifteen elements |
| Administrative resolution | Resolución Administrativa N° 0020/2025 (issued 2 October 2025, effective 13 October 2025) | Anexo I, Article 7 item 2, NOTA | Expiry format is dd/mm/aaaa; where the invoice shows only month and year, the last day of the month is entered (sep/2026 becomes 30/09/2026) |
| Administrative resolution | Resolución Administrativa N° 0020/2025 (issued 2 October 2025, effective 13 October 2025) | Anexo I, Article 7 item 3 | DDM may request any further documents it considers necessary |
| Administrative resolution | Resolución Administrativa N° 0020/2025 (issued 2 October 2025, effective 13 October 2025) | Anexo I, Article 8 items 1 to 8 | Eight steps: platform application, login, submission, online payment, DDM review and opinion, new filing if rejected, system-generated authorisation on approval, customs clearance on that document |
| Administrative resolution | Resolución Administrativa N° 0020/2025 (issued 2 October 2025, effective 13 October 2025) | Anexo I, Articles 9 and 10 | Reconsideration and appeal against rejection, ten working days each, available once at each level |
| Circular | Circular ANRS-DDM-BRML-0001-03-2026 (ANRS Medical Device Directorate, 25 March 2026, effective 13 April 2026) | Points 1, 2, 3 and 4 | Transitional provisions terminated; all device sanitary registrations of authorised distributors loaded into Karplus; from 13 April 2026 all device imports handled through VUCEN |
3. Expert insights
Insight one: the fifteen elements are numbered 3.1 to 3.15 in the official text, but sit under item 2 of Article 7. The sub-numbering does not match the level at which it is placed. It is the sixth numbering inconsistency identified in the official texts during this review. The substance is unaffected: there are fifteen elements, matching the common description of a fifteen-element invoice.
Insight two: the invoice is checked against the registration, item by item. Element 3.1 requires the product name «según lo registrado» and 3.2 the packaging specification «según los registrado». In Nicaragua the invoice is not a purely commercial document but evidence compared against the registration certificate, so a name or specification that departs from the certificate is stopped at review.
Insight three: the expiry format rule is unusually concrete. Article 7 item 2 supplies an example: a month-only date becomes the last day of the month (sep/2026 becomes 30/09/2026). The rule settles a recurring documentary dispute over batch expiry, and it means the date on the invoice may run a few days beyond what the manufacturer printed on the label.
Insight four: a rejected import application has no correction window. Article 8 item 6 states «Si la solicitud es rechazada el tramitador deberá realizar un nuevo trámite» — the application must be lodged afresh. The same approach applies to classification applications (Annex D, Article 5) and CLV (Annex E, Article 5), and it differs from the correction mechanism used at pre-assessment and assessment in the registration track.
Insight five: remedies mirror the registration track. Reconsideration and appeal each run for ten working days, once at each level, and reconsideration does not suspend the original act (Articles 9 and 10). This corresponds sentence for sentence with Articles 16 and 17 of Anexo I to RA 0007/2025, so the route against an import rejection runs parallel to the route against a registration refusal.
Insight six: the circular marks the end of the transition. It cites Articles 12 and 13 of Chapter VII of Anexo I to RA 0020/2025 to terminate the transitional provisions and requires VUCEN for all imports from 13 April 2026. Point 2 also records that all device sanitary registrations of authorised distributors have been loaded into Karplus — the data bridge between the two platforms, and the precondition for a registration number being searchable in VUCEN.
4. Practical recommendations
- Complete all fifteen invoice elements in one pass, and in particular do not omit the Nicaraguan registration number, batch number, unit of measure or FOB value.
- Compare the product name and packaging specification on the invoice word for word against the certificate (elements 3.1 and 3.2).
- Write every expiry date as dd/mm/aaaa, using the last day of the month where only month and year appear.
- On rejection, file again immediately rather than waiting for a correction window — Article 8 item 6 provides none.
- If the rejection is contested, file reconsideration within ten working days and then appeal within a further ten, once at each level.
- Confirm that the registration number has been loaded into Karplus with the distributor (Circular 0001-03-2026, point 2), otherwise the VUCEN application cannot be matched.
5. Verification checklist
- □ The invoice carries all fifteen elements, including registration number, batch number, unit of measure and FOB value
- □ Product name and packaging specification have been checked word for word against the certificate
- □ Expiry dates follow dd/mm/aaaa, and month-only dates use the last day of the month
- □ It is understood that a rejected import application has no correction window and must be refiled
- □ Reminders are set for ten working days for reconsideration and ten for appeal
- □ The registration number has been confirmed as loaded into Karplus with the distributor
Regulatory information verified as of 29 October 2026.
How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Nicaraguan market. Our team manages Ministry of Health (MINSA) sanitary registration applications, prepares Spanish-language dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us